Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Cutting costs during the holiday season can enhance your savings. Explore practical ways to save money while celebrating joyfully.
20,661 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Bitcoin climbs to a six-week peak near $74,000 as pepe explodes amid altcoin momentum. Major tokens follow, with ETH ...
New heart health guidelines urge Lp(a) testing for at-risk adults, sending demand for diagnostics higher. This report...
Meta is developing an AI-powered companion for CEO Mark Zuckerberg to streamline decisions and model AI adoption at t...
Indonesian telecoms chief Vikram Sinha is leading Indosat into sovereign AI territory, threading local-language model...
A consortium of Japanese enterprises plans to issue a yen-pegged stablecoin for B2B settlements, running on Ethereum ...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A leaked Meta audio from an April 30 all-hands meeting signals a shift toward leveraging compute and internal output ...
SpaceX is shaping up to launch its IPO, and the idea of could buying spacex stock sounds thrilling. This guide breaks...
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Last month, sandisk stock skyrocketed 54.6% as AI-driven sentiment surged. This article breaks down the factors behin...
As workers start removing Trump’s name from the Kennedy Center, the nation’s capital watches a symbolic change that c...